Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$11.7M Buy
22,051
+3,438
+18% +$1.69M 0.03% 487
2020
Q3
$8.94M Buy
18,613
+1,398
+8% +$686K 0.03% 512
2020
Q2
$7.77M Sell
17,215
-2,122
-11% -$947K 0.03% 554
2020
Q1
$8.38M Sell
19,337
-1,768
-8% -$790K 0.04% 474
2019
Q4
$9.27M Sell
21,105
-2,860
-12% -$1.2M 0.03% 521
2019
Q3
$10M Buy
23,965
+6,072
+34% +$2.48M 0.04% 473
2019
Q2
$6.46M Buy
17,893
+3,303
+23% +$1.1M 0.03% 618
2019
Q1
$4.67M Buy
14,590
+156
+1% +$47.9K 0.02% 728
2018
Q4
$4.09M Sell
14,434
-2,858
-17% -$862K 0.02% 715
2018
Q3
$5.53M Buy
17,292
+1,943
+13% +$619K 0.02% 642
2018
Q2
$4.94M Sell
15,349
-128
-0.8% -$40.1K 0.02% 672
2018
Q1
$4.22M Buy
15,477
+221
+1% +$58.5K 0.02% 716
2017
Q4
$3.71M Buy
15,256
+205
+1% +$46.6K 0.02% 752
2017
Q3
$3.04M Sell
15,051
-494
-3% -$97.1K 0.02% 787
2017
Q2
$3.18M Buy
15,545
+1,011
+7% +$201K 0.02% 739
2017
Q1
$2.65M Buy
14,534
+668
+5% +$116K 0.02% 765
2016
Q4
$2.23M Sell
13,866
-32,336
-70% -$4.75M 0.02% 780
2016
Q3
$6.52M Sell
46,202
-259
-0.6% -$36.1K 0.05% 453
2016
Q2
$6.33M Sell
46,461
-1,104
-2% -$146K 0.05% 434
2016
Q1
$6.44M Sell
47,565
-747
-2% -$101K 0.06% 393
2015
Q4
$7.24M Sell
48,312
-27,426
-36% -$4.05M 0.07% 332
2015
Q3
$10.1M Buy
75,738
+113
+0.1% +$15.8K 0.1% 231
2015
Q2
$9.91M Buy
75,625
+1,153
+2% +$143K 0.1% 243
2015
Q1
$8.89M Buy
74,472
+34,619
+87% +$3.84M 0.1% 247
2014
Q4
$4.21M Buy
39,853
+36,154
+977% +$3.82M 0.05% 425
2014
Q3
$381K Buy
3,699
+369
+11% +$37.4K 0.01% 1267
2014
Q2
$312K Buy
3,330
+1,062
+47% +$94.2K ﹤0.01% 1377
2014
Q1
$203K Buy
+2,268
New +$185K ﹤0.01% 1859

Other funds holding CHE

Aperio Group's CHE Position: Q4 2020 in Review

Aperio Group increased its Chemed (CHE) stake by 18% in Q4 2020, buying an estimated $1.69M and bringing the position to 22,051 shares worth $11.7M. The position accounts for 0.03% of the portfolio, ranked #487.

Aperio Group first reported a position in CHE in Q1 2014 and has held it in 28 quarters since. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2020.

  • Aperio Group held 22,051 shares of Chemed worth $11.7M as of Q4 2020.
  • Aperio Group bought 3,438 Chemed shares in Q4 2020, an estimated $1.69M.
  • Chemed made up 0.03% of Aperio Group's portfolio in Q4 2020, its #487 holding.
  • Aperio Group first reported a position in Chemed in Q1 2014 and has held it in 28 quarters since.
  • 442 funds tracked by Wall St. Rank held Chemed as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.